Roger Belizaire, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proto-Oncogene Proteins c-cbl | 1 | 2021 | 117 | 0.820 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2021 | 78 | 0.820 |
Why?
|
Platelet Transfusion | 2 | 2020 | 285 | 0.810 |
Why?
|
Blood Donors | 1 | 2022 | 355 | 0.800 |
Why?
|
Photopheresis | 1 | 2019 | 30 | 0.740 |
Why?
|
src-Family Kinases | 1 | 2021 | 569 | 0.680 |
Why?
|
Spleen | 2 | 2020 | 2473 | 0.580 |
Why?
|
Cytapheresis | 1 | 2015 | 7 | 0.580 |
Why?
|
Isoantibodies | 1 | 2019 | 660 | 0.560 |
Why?
|
Erythrocytes, Abnormal | 1 | 2015 | 114 | 0.550 |
Why?
|
Polycythemia | 1 | 2015 | 117 | 0.530 |
Why?
|
Iron | 1 | 2022 | 1710 | 0.520 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2015 | 222 | 0.510 |
Why?
|
Erythrocytes | 2 | 2022 | 2418 | 0.490 |
Why?
|
HLA Antigens | 1 | 2019 | 1549 | 0.470 |
Why?
|
Thrombocytopenia | 1 | 2020 | 1136 | 0.470 |
Why?
|
Paraproteinemias | 1 | 2015 | 242 | 0.470 |
Why?
|
Interleukin-2 | 1 | 2019 | 1936 | 0.440 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2021 | 2593 | 0.440 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 2936 | 0.420 |
Why?
|
Erythropoietin | 1 | 2015 | 731 | 0.400 |
Why?
|
Blood Platelets | 1 | 2020 | 2485 | 0.380 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 1938 | 0.350 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2010 | 1537 | 0.340 |
Why?
|
Graft vs Host Disease | 1 | 2019 | 2818 | 0.310 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8896 | 0.300 |
Why?
|
Hematopoietic Stem Cells | 2 | 2017 | 3447 | 0.290 |
Why?
|
Kidney Diseases | 1 | 2015 | 2124 | 0.250 |
Why?
|
Synaptic Vesicles | 2 | 2004 | 210 | 0.240 |
Why?
|
Cytokine Receptor Common beta Subunit | 1 | 2022 | 23 | 0.240 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2009 | 1418 | 0.230 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2022 | 193 | 0.220 |
Why?
|
Hematopoiesis | 2 | 2022 | 2015 | 0.200 |
Why?
|
Splenomegaly | 1 | 2020 | 192 | 0.200 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2019 | 101 | 0.180 |
Why?
|
Platelet Count | 1 | 2020 | 794 | 0.170 |
Why?
|
Histocompatibility | 1 | 2019 | 362 | 0.160 |
Why?
|
Histocompatibility Testing | 1 | 2019 | 804 | 0.160 |
Why?
|
Nerve Tissue Proteins | 3 | 2004 | 4592 | 0.150 |
Why?
|
Dendritic Cells | 3 | 2011 | 2726 | 0.130 |
Why?
|
Benzylamines | 1 | 2015 | 230 | 0.130 |
Why?
|
Multienzyme Complexes | 3 | 2003 | 769 | 0.130 |
Why?
|
Treatment Failure | 1 | 2020 | 2680 | 0.130 |
Why?
|
Heterocyclic Compounds | 1 | 2015 | 271 | 0.130 |
Why?
|
Bone Marrow Neoplasms | 1 | 2014 | 108 | 0.120 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2019 | 3055 | 0.120 |
Why?
|
Sodium Chloride, Dietary | 1 | 2015 | 253 | 0.120 |
Why?
|
Immunity | 1 | 2019 | 957 | 0.120 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 1860 | 0.120 |
Why?
|
Substantia Nigra | 3 | 2003 | 358 | 0.110 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2015 | 637 | 0.110 |
Why?
|
Immediate-Early Proteins | 1 | 2015 | 459 | 0.110 |
Why?
|
Myeloproliferative Disorders | 1 | 2017 | 591 | 0.110 |
Why?
|
Leukocyte Count | 1 | 2015 | 1670 | 0.100 |
Why?
|
Cysteine Endopeptidases | 3 | 2003 | 655 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2010 | 97 | 0.100 |
Why?
|
Listeriosis | 1 | 2011 | 161 | 0.100 |
Why?
|
Brefeldin A | 1 | 2009 | 71 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2019 | 2165 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1687 | 0.090 |
Why?
|
Muramidase | 1 | 2009 | 176 | 0.090 |
Why?
|
Listeria monocytogenes | 1 | 2011 | 260 | 0.090 |
Why?
|
Syndrome | 1 | 2015 | 3177 | 0.090 |
Why?
|
Membrane Glycoproteins | 3 | 2004 | 3812 | 0.090 |
Why?
|
Chloroquine | 1 | 2009 | 288 | 0.080 |
Why?
|
Mutation | 3 | 2022 | 29262 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2019 | 4383 | 0.080 |
Why?
|
Chickens | 1 | 2009 | 875 | 0.080 |
Why?
|
Humans | 15 | 2022 | 708843 | 0.080 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2022 | 3281 | 0.080 |
Why?
|
Receptors, IgG | 1 | 2010 | 612 | 0.080 |
Why?
|
Membrane Proteins | 1 | 2004 | 8072 | 0.080 |
Why?
|
Liposomes | 1 | 2009 | 754 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4254 | 0.070 |
Why?
|
Endocytosis | 1 | 2009 | 1018 | 0.070 |
Why?
|
Mice, Inbred NOD | 1 | 2009 | 1918 | 0.070 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 997 | 0.070 |
Why?
|
Chronic Disease | 1 | 2019 | 8992 | 0.060 |
Why?
|
Genome, Human | 1 | 2017 | 4493 | 0.060 |
Why?
|
Striatonigral Degeneration | 1 | 2002 | 13 | 0.060 |
Why?
|
Brain | 4 | 2004 | 24969 | 0.060 |
Why?
|
Complement Inactivator Proteins | 1 | 2002 | 84 | 0.060 |
Why?
|
Ubiquitination | 2 | 2022 | 998 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2019 | 10803 | 0.060 |
Why?
|
Interleukin-5 | 1 | 2022 | 259 | 0.060 |
Why?
|
Protein Isoforms | 2 | 2004 | 1712 | 0.060 |
Why?
|
Interleukin-3 | 1 | 2022 | 439 | 0.050 |
Why?
|
Graft Rejection | 1 | 2015 | 4408 | 0.050 |
Why?
|
Mice | 9 | 2017 | 80876 | 0.050 |
Why?
|
Inclusion Bodies | 1 | 2002 | 277 | 0.050 |
Why?
|
Acetylcysteine | 1 | 2002 | 287 | 0.050 |
Why?
|
Male | 5 | 2022 | 349524 | 0.050 |
Why?
|
Parkinson Disease | 3 | 2003 | 2578 | 0.050 |
Why?
|
Protein Stability | 1 | 2022 | 569 | 0.050 |
Why?
|
Models, Biological | 1 | 2017 | 9907 | 0.050 |
Why?
|
Lymph Nodes | 1 | 2011 | 3409 | 0.050 |
Why?
|
Peptide Hydrolases | 1 | 2003 | 682 | 0.050 |
Why?
|
Calcium-Binding Proteins | 1 | 2004 | 1101 | 0.050 |
Why?
|
Time Factors | 2 | 2019 | 41038 | 0.050 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 903 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 3026 | 0.050 |
Why?
|
Signal Transduction | 2 | 2021 | 23950 | 0.040 |
Why?
|
Aged | 4 | 2019 | 161488 | 0.040 |
Why?
|
Female | 4 | 2022 | 375205 | 0.040 |
Why?
|
Animals | 11 | 2017 | 170486 | 0.040 |
Why?
|
Zygote | 1 | 2017 | 127 | 0.040 |
Why?
|
Neurons | 4 | 2003 | 9385 | 0.040 |
Why?
|
Antigens, CD34 | 1 | 2017 | 673 | 0.040 |
Why?
|
Macrophages | 1 | 2009 | 5784 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1767 | 0.030 |
Why?
|
Middle Aged | 2 | 2019 | 213752 | 0.030 |
Why?
|
Treatment Outcome | 1 | 2019 | 61932 | 0.030 |
Why?
|
Retinal Rod Photoreceptor Cells | 2 | 2004 | 215 | 0.030 |
Why?
|
Retina | 1 | 2003 | 2649 | 0.030 |
Why?
|
Graft Survival | 1 | 2002 | 3767 | 0.030 |
Why?
|
Integrin alpha Chains | 1 | 2011 | 101 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 3 | 2003 | 1461 | 0.030 |
Why?
|
Apoptosis | 2 | 2011 | 10085 | 0.030 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2011 | 153 | 0.030 |
Why?
|
Dopamine | 3 | 2003 | 1584 | 0.030 |
Why?
|
Hemorrhage | 1 | 2022 | 3235 | 0.020 |
Why?
|
Leukemia | 1 | 2017 | 1496 | 0.020 |
Why?
|
Hashimoto Disease | 1 | 2010 | 93 | 0.020 |
Why?
|
Cell Line | 1 | 2004 | 16657 | 0.020 |
Why?
|
Protein Subunits | 2 | 2003 | 1021 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2011 | 1922 | 0.020 |
Why?
|
Cell Lineage | 1 | 2017 | 2630 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2010 | 965 | 0.020 |
Why?
|
Virulence | 1 | 2011 | 1324 | 0.020 |
Why?
|
Cell Separation | 2 | 2003 | 1835 | 0.020 |
Why?
|
Encephalitis | 1 | 2010 | 446 | 0.020 |
Why?
|
Tyrosine | 1 | 2010 | 1477 | 0.020 |
Why?
|
Phagocytosis | 1 | 2011 | 1594 | 0.020 |
Why?
|
Syntaxin 1 | 1 | 2004 | 30 | 0.020 |
Why?
|
Lysosomes | 1 | 2010 | 941 | 0.020 |
Why?
|
Synaptotagmins | 1 | 2004 | 60 | 0.020 |
Why?
|
Synaptotagmin I | 1 | 2004 | 41 | 0.020 |
Why?
|
Adult | 1 | 2019 | 211041 | 0.020 |
Why?
|
SNARE Proteins | 1 | 2004 | 96 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2010 | 1303 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2003 | 11790 | 0.020 |
Why?
|
Amacrine Cells | 1 | 2003 | 54 | 0.020 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2002 | 72 | 0.020 |
Why?
|
Lymphocytes | 1 | 2011 | 2729 | 0.010 |
Why?
|
Exocytosis | 1 | 2004 | 365 | 0.010 |
Why?
|
Complement C5 | 1 | 2002 | 116 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 12863 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2011 | 15274 | 0.010 |
Why?
|
Brain Tissue Transplantation | 1 | 2002 | 86 | 0.010 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2002 | 217 | 0.010 |
Why?
|
Parkinson Disease, Secondary | 1 | 2002 | 126 | 0.010 |
Why?
|
Fetal Tissue Transplantation | 1 | 2002 | 173 | 0.010 |
Why?
|
Vesicular Transport Proteins | 1 | 2004 | 383 | 0.010 |
Why?
|
Retinal Cone Photoreceptor Cells | 1 | 2003 | 192 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2015 | 22989 | 0.010 |
Why?
|
Brain Diseases | 1 | 2010 | 1530 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 2002 | 8593 | 0.010 |
Why?
|
Mesencephalon | 1 | 2002 | 322 | 0.010 |
Why?
|
Antigens, CD | 1 | 2011 | 4169 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2017 | 5135 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2011 | 3075 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2011 | 2937 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2004 | 1162 | 0.010 |
Why?
|
Organ Specificity | 1 | 2003 | 2064 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2002 | 1589 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2003 | 3879 | 0.010 |
Why?
|
Rats | 2 | 2002 | 25094 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2014 | 18375 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2004 | 6850 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2002 | 2427 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2022 | 71483 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2002 | 4831 | 0.010 |
Why?
|
Blotting, Western | 1 | 2002 | 5456 | 0.010 |
Why?
|
Synapses | 1 | 2003 | 1706 | 0.010 |
Why?
|
Swine | 1 | 2002 | 5763 | 0.010 |
Why?
|
Cell Survival | 1 | 2002 | 6156 | 0.010 |
Why?
|
Protein Binding | 1 | 2004 | 9639 | 0.010 |
Why?
|
Calcium | 1 | 2004 | 5825 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 11239 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2002 | 20170 | 0.000 |
Why?
|